The Island20h
Haleon partners Sri Lanka Dental Association as Official Sponsor for World Oral Health Day 2025
Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing ...
GSK, Pfizer's ViiV Healthcare Shows Strong HIV Viral Suppression In Latest Study
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
Asian News International on MSN3d
Sensodyne Sets a GUINNESS WORLD RECORD™️ to kickstart 2025 World Oral Health Day campaign
Dental Screenings completed in 1 Day at Maha KumbhWorld Oral Health Day campaign will educate people on importance of good ...
Le Lézard2d
ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...
Le Lézard2d
ViiV Healthcare's investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company's EMBRACE phase IIb study.1 The ...
Fierce Pharma1d
Amid Vafseo's US launch, Akebia plots phase 3 study to grow CKD anemia med's reach
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...
PharmiWeb1d
ViiV Healthcare announces new implementation study…
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...